Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-YANG Quadrivalent Seasonal Influenza Vaccine in Healthy Infants
NCT04381689Phase 3Completed
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Oct 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doramectin in influenza, sponsored by Il-Yang Pharmaceutical. Started Oct 2024; status: completed.
02
Drugs
doramectin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04381689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04381689.